MD
Associate Professor, Medicine
Joint Faculty, Department of Microbiology and Immunology
UNC-Chapel Hill
Immunology
Area of Interest
The Vincent Lab works in the areas of systems tumor immunology and immunogenomics, to better understand anti-tumor immunity and translate this into curative immunotherapy strategies.
Awards and Honors
- Biological and Biomedical Sciences Faculty Mentor Award, UNC-Chapel Hill, 2022
- Invited speaker, Immuno-Oncology Young Investigators Forum, 2016
- Pope Clinical Fellow Award, Lineberger Comprehensive Cancer Center, 2015
- Outstanding Fellow Award, North Carolina Oncology Association, 2015
- Invited speaker, Illumina Users Group Meeting, 2015
- Outstanding Abstract Travel Award, American Society of Hematology, 2013
- Farmer Award for Compassion in Medicine, UNC Hospitals Department of Internal Medicine, 2010
- David A. Ontjes Outstanding Intern Award, UNC Hospitals Department of Internal Medicine, 2010
- Competitive Selection to ABIM Research Track, UNC Department of Hematology/Oncology, 2009
- John B. Graham Medical Student Research Society, University of North Carolina, 2008
- Harold C. Pillsbury Basic Science Award, University of North Carolina School of Medicine, 2008
- Holderness Research Fellowship, University of North Carolina School of Medicine, 2005
News and Stories
Scientific retreat underscores impact and promise of cancer center’s research
UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
Pylayeva-Gupta published in Cell Reports Medicine
UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, was the corresponding author of a paper published in Cell Reports Medicine that examined how B cells might be reprogrammed to improve anti-tumor immune response in pancreatic cancer. The study was led by a former research associate, Rahul Mirlekar.
